A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304975/
https://www.ncbi.nlm.nih.gov/pubmed/28223773
http://dx.doi.org/10.2147/OPTH.S116038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304975/
https://www.ncbi.nlm.nih.gov/pubmed/28223773
http://dx.doi.org/10.2147/OPTH.S116038

Ejemplares similares